Increase in neuroendocrine cells in the duodenal mucosa of patients with refractory celiac disease

American Journal of Gastroenterology

Volumn 109, Issue 2, 2014, Pages 258-269

  Di Sabatino, Antonio ^a   Giuffrida, Paolo ^a   Vanoli, Alessandro ^a   Luinetti, Ombretta ^a   Manca, Rachele ^a   Biancheri, Paolo ^a   Bergamaschi, Gaetano ^a   Alvisi, Costanza ^a   Pasini, Alessandra ^a   Salvatore, Chiara ^a   Biagi, Federico ^a   Solcia, Enrico ^a   Corazza, Gino Roberto ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; CELIAC DISEASE; DIET, GLUTEN-FREE; DUODENOSCOPY; DUODENUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NEUROENDOCRINE CELLS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REFERENCE VALUES; RETROSPECTIVE STUDIES; RNA, MESSENGER; SEROTONIN; SOMATOSTATIN; STATISTICS, NONPARAMETRIC; TREATMENT FAILURE; UP-REGULATION;

EID: 84893791509     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.426     Document Type: Article

References (41)

1. Rindi G, Leiter AB, Kopin AS et al. The " normal " endocrine cell of the gut: changing concepts and new evidences. Ann N Y Acad Sci 2004; 1014: 1-12.
2. Facer P, Bishop AE, Lloyd RV et al. Chromogranin: a newly recognized marker for endocrine cells of the human gastrointestinal tract. Gastroenterology 1985; 89: 1366-73.
3. Sjölund K, Sandén G, Håkanson R et al. Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology 1983; 85: 1120-30.
4. Walther DJ, Peter JU, Bashammakh S et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 2003; 299: 76.
5. Wade PR, Chen J, Jaff e B et al. Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract. J Neurosci 1996; 16: 2352-64.
6. Khan WI, Ghia JE. Gut hormones: emerging role in immune activation and infl ammation. Clin Exp Immunol 2010; 161: 19-27.
7. Stefulj J, Cicin-Sain L, Schauenstein K et al. Serotonin and immune response: effect of the amine on in vitro proliferation of rat lymphocytes. Neuroimmunomodulation 2001; 9: 103-8.
8. Laberge S, Cruikshank WW, Beer DJ et al. Secretion of IL-16 (lymphocyte chemoattractant factor) from serotonin-stimulated CD8+ T cells in vitro. J Immunol 1996; 156: 310-5.
9. Betten A, Dahlgren C, Hermodsson S et al. Serotonin protects NK cells against oxidatively induced functional inhibition and apoptosis. J Leukoc Biol 2001; 70: 65-72.
10. Soga F, Katoh N, Inoue T et al. Serotonin activates human monocytes and prevents apoptosis. J Invest Dermatol 2007; 127: 1947-55.
11. Li N, Ghia JE, Wang H et al. Serotonin activates dendritic cell function in the context of gut infl ammation. Am J Pathol 2011; 178: 662-71.
12. Ghia JE, Li N, Wang H et al. Serotonin has a key role in pathogenesis of experimental colitis. Gastroenterology 2009; 137: 1649-60.
13. Leon-Ponte M, Ahern GP, O'Connell PJ. Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor. Blood 2007; 109: 3139-46.
14. El-Salhy M, Danielsson A, Stenling R et al. Colonic endocrine cells in infl ammatory bowel disease. J Intern Med 1997; 242: 413-9.
15. Dunlop SP, Jenkins D, Neal KR et al. Relative importance of enterochromaffi n cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003; 125: 1651-9.
16. Di Sabatino A, Corazza GR. Coeliac disease. Lancet 2009; 379: 1480-93.
17. Polak JM, Pearse AG, Van Noorden S et al. Secretin cells in coeliac disease. Gut 1973; 14: 870-4.
18. Challacombe DN, Robertson K. Letter: Enterochromaffi n cells and coeliac disease. Lancet 1976; 1: 370-1.
19. Sjölund K, Alumets J, Berg NO et al. Duodenal endocrine cells in adult coeliac disease. Gut 1979; 20: 547-52.
20. Sjölund K, Alumets J, Berg NO et al. Enteropathy of coeliac disease in adults: increased number of enterochromaffi n cells in the duodenal mucosa. Gut 1982; 23: 42-8.
21. Sjölund K, H å kanson R, Lundqvist G et al. Duodenal somatostatin in coeliac disease. Scand J Gastroenterol 1982; 17: 969-76.
22. Enerb ä ck L, Hallert C, Norrby K. Raised 5-hydroxytryptamine concentrations in enterochromaffi n cells in adult coeliac disease. J Clin Pathol 1983; 36: 499-503.
23. Buchan AM, Grant S, Brown JC et al. A quantitative study of enteric endocrine cells in celiac sprue. J Pediatr Gastroenterol Nutr 1984; 3: 665-71.
24. Wheeler EE, Challacombe DN. Quantifi cation of enterochromaffi n cells with serotonin immunoreactivity in the duodenal mucosa in coeliac disease. Arch Dis Child 1984; 59: 523-7.
25. Pietroletti R, Bishop AE, Carlei F et al. Gut endocrine cell population in coeliac disease estimated by immunocytochemistry using a monoclonal antibody to chromogranin. Gut 1986; 27: 838-43.
26. Moyana TN, Shukoor S. Gastrointestinal endocrine cell hyperplasia in celiac disease: a selective proliferative process of serotonergic cells. Mod Pathol 1991; 4: 419-23.
27. Coleman NS, Foley S, Dunlop SP et al. Abnormalities of serotonin metabolism and their relation to symptoms in untreated celiac disease. Clin Gastroenterol Hepatol 2006; 4: 874-81.
28. Di Sabatino A, Biagi F, Gobbi PG et al. How I treat enteropathy- associated T-cell lymphoma. Blood 2012; 119: 2458-68.
29. Rubio-Tapia A, Murray JA. Classifi cation and management of refractory coeliac disease. Gut 2010; 59: 547-57.
30. Biagi F, Trotta L, Alfano C et al. Prevalence and natural history of potential celiac disease in adult patients. Scand J Gastroenterol 2013; 48: 537-42.
31. Monteleone I, Monteleone G, Del Vecchio Blanco G et al. Regulation of the T helper cell type 1 transcription factor T-bet in coeliac disease mucosa. Gut 2004; 53: 1090-5.
32. Corazza GR, Villanacci V. Coeliac disease. J Clin Pathol 2005; 58: 573-4.
33. Di Sabatino A, Pickard KM, Gordon JN et al. Evidence for the role of interferon-alfa production by dendritic cells in the Th 1 response in celiac disease. Gastroenterology 2007; 133: 1175-87.
34. Turvill JL, Connor P, Farthing MJ. The inhibition of cholera toxin-induced 5-HT release by the 5-HT(3) receptor antagonist, granisetron, in the rat. Br J Pharmacol 2000; 130: 1031-6.
35. Nowak EC, de Vries VC, Wasiuk A et al. Tryptophan hydroxylase-1 regulates immune tolerance and infl ammation. J Exp Med 2012; 209: 2127-35.
36. O'Connell PJ, Wang X, Leon-Ponte M et al. A novel form of immune signaling revealed by transmission of the infl ammatory mediator serotonin between dendritic cells and T cells. Blood 2006; 107: 1010-7.
37. Foley S, Garsed K, Singh G et al. Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation. Gastroenterology 2011; 140: 1434-43.
38. Kerckhoff s AP, Ter Linde JJ, Akkermans LM et al. Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients. Neurogastroenterol Motil 2008; 20: 900-7.
39. Di Sabatino A, Ciccocioppo R, D ' Al ò S et al. Intraepithelial and lamina propria lymphocytes show distinct patterns of apoptosis, whereas both the populations are active in Fas-based cytotoxicity in coeliac disease. Gut 2001; 49: 380-6.
40. Penman E, Wass JA, Butler MG et al. Distribution and characterisation of immunoreactive somatostatin in human gastrointestinal tract. Regul Pept 1983; 7: 53-65.
41. Wang H, Steeds J, Motomura Y et al. CD4+ T cell-mediated immunological control of enterochromaffi n cell hyperplasia and 5-hydroxytryptamine production in enteric infection. Gut 2007; 56: 949-57.